Alliance Pharma (APH.L) Stock Price
£61.4 0.3%
to add to portfolio
AI Score

-
Alternative
4 -
Fundamental
6 -
Technical
9
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Alliance Pharma, AI stock picks, stock alerts and much more.
APH.L AI Stock Analysis
AI stock analysis for APH.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Alliance Pharma (APH.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Alliance Pharma (APH.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Alliance Pharma (APH.L), currently trading at £61.4, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About APH.L

-
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.
-
Symbol
APH.L
-
Market
LSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
331.9M
Similar Stocks
![]() |
DMK Pharmaceuticals 0A4X.L |
$0.0009 0.00% |
6 |
![]() |
Shield Therapeutics STX.L |
£3.07 9.2% |
4 |
![]() |
Indivior PLC INDV.L |
£842.5 3.8% |
5 |
![]() |
Haleon plc HLN.L |
£379 0.2% |
6 |
![]() |
HUTCHMED (China) Limited HCM.L |
£225.1 1.6% |
5 |
News
APH.L Alternative Data
Web Traffic
Alliance Pharma receives an estimated 6519 monthly visitors to alliancepharmaceuticals.com.
-
Web Traffic
6519
-
Change from Previous Month
23.8%
-
3 Month Change
37.9%
News Mentions
Alliance Pharma was mentioned 3 times in the news yesterday.
-
News Mentions
3
-
Daily Change
25%
-
1 Month Change
0%
-
3 Month Change
200%
LinkedIn Followers
17,235 are following Alliance Pharma on LinkedIn, up by 3% over the last month.
-
LinkedIn Followers
17235
-
Daily Change
0%
-
1 Month Change
3%
-
3 Month Change
5.1%
Job Postings
Alliance Pharma currenly has an estimated 3 open job postings.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Alliance Pharma has 510 employees, up by 0.4% over the last month.
-
LinkedIn Employees
510
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.2%
Business Outlook
-
Business Outlook
62
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
APH.L Financials
APH.L Key Metrics
-
Total Revenue
£83.9M
-
Net Income
£4.7M
-
Earnings per Share
£0.0086
-
Free cash flow
£8.8M
-
EBITDA
£15.7M
-
EBITDA Ratio
0.187396
-
Total Assets
£398.3M
APH.L 2-year Revenue & Income
APH.L 2-year Free Cash Flow
APH.L Technicals
APH.L SMA
APH.L RSI
FAQ
What's the current price of Alliance Pharma (APH.L) Stock?
The price of an Alliance Pharma (APH.L) share is £61.4.
What's the market cap of Alliance Pharma?
The current market cap of Alliance Pharma is 331.9M.
Should I buy or sell APH.L?
Alliance Pharma shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Alliance Pharma is better viewed as a hold or accumulate position while waiting for further developments.
Is Alliance Pharma a good investment?
The current analysis of Alliance Pharma's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Alliance Pharma's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Alliance Pharma (APH.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Alliance Pharma stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Alliance Pharma (APH.L) that investors often compare it to?
Alliance Pharma (APH.L) is often compared to similar stocks such as DMK Pharmaceuticals, Shield Therapeutics, Indivior PLC, Haleon plc and HUTCHMED (China) Limited.
What is the forecast for Alliance Pharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Alliance Pharma's stock price to be around £62.22 in 2026. Starting from the current price of £61.4, this represents a 1.3% change in price, indicating a neutral outlook for the stock.
How to buy Alliance Pharma (APH.L) Stock?
Alliance Pharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Alliance Pharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.